Federal lawmakers have a fresh resource to keep them up on healthcare AI that falls outside of formal FDA oversight. It comes in the form of a new report from the nonprofit Bipartisan Policy Center.

Imaging experts advocate for “meticulous assessments” of cases that include luminal cancer, dense breasts, and lesions located outside the mammary zone, among other factors. 

Patients who frequently use AI tend to readily trust AI-assisted diagnoses made by their physicians. Counterintuitively, however, those who would rank themselves among the very best-informed about AI tend to mistrust such diagnoses. 

The opportunistic screening helps identify patients in need of monitoring and/or intervention without disrupting workflows.

States’ rights or federal power? Senate Republicans are of two minds on AI regulation in the One Big Beautiful Bill. 

From the perspective of management science, healthcare is a complex adaptive system marked by intricate feedback loops and overlapping interdependencies. As such, the sector demands caution by those introducing large-language AI into its tangled webs. 

The apps are embedded into the Exo Iris transducer, which can be plugged directly into a smartphone, utilized anywhere and without the internet. 

Tennr uses an “enterprise orchestration engine” and series of specialized language models, trained on the nuances of processing documentation against payer criteria.